Table 3:

Evolution of aneurysm occlusion relating to clinical factors and immediate postoperative aneurysm occlusion

Stable or ImprovedWorsenedP Value
No% (95% CI)No% (95% CI)
SexFemale (311)15951.1 (45.4–56.8)15248.9 (43.2–54.6).426
Male (202)9647.5 (40.5–54.7)10652.5 (45.3–59.5)
Age<65 years (446)21347.8 (43.0–52.5)23352.2 (47.5–57.0).024
≥65 years (67)4262.7 (50.0–74.2)2537.3 (25.8–50.0)
HypertensionYes (144)7451.4 (42.9–59.8)7048.6 (40.2–57.1).634
No (369)18149.1 (43.8–54.3)18850.9 (45.7–56.2)
SmokingYes (225)10948.4 (41.8–55.2)11651.6 (44.8–58.3).613
No (288)14650.7 (44.8–56.6)14249.3 (43.4–55.2)
WFNS≤2 (390)18948.5 (43.4–53.6)20151.5 (46.5–56.6).315
>2 (123)6653.6 (44.4–62.7)5746.3 (37.3–55.6)
Postop. aneurysm occlusionAO (460)23150.2 (45.6–54.9)22949.8 (45.1–54.5).497
AR (53)2445.3 (31.6–59.6)2954.7 (40.4–68.4)
  • Note:—AO indicates adequate occlusion; AR, aneurysm remnant; CI, confidence interval; postop., postoperative